Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,433 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,452 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05918224 | Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy | completed | Phase 2 | 160 | West China HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT04608773 | Blinded Dry Mouth Spray Crossover Study | completed | N/A | 129 | Jonas JohnsonOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT05936502 |
| Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer(EPIC-iENE DATA) |
| completed |
| — |
| 3,500 |
| Head and Neck Cancer International GroupOTHER |
| 8 |
| Feb 1, 2024 |
| clinicaltrials |
| NCT03691207 | A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations(ACCURACY) | completed | Phase 2 | 87 | Ayala Pharmaceuticals, Inc,INDUSTRY | 6 | Jan 31, 2024 | clinicaltrials |
| NCT01437449 | Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 27 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02369835 | Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 3 | 132 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02609386 | IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity(INSPIRE) | completed | Phase 2 | 105 | Brooklyn ImmunoTherapeutics, LLCINDUSTRY | 4 | Jan 30, 2024 | clinicaltrials |
| NCT03266276 | Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics | completed | N/A | 98 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT05056064 | Efficacy of Swallowing Function After Early Postoperative Oral Exercise Among Patient With Oral Cavity Cancer Underwent Flap Reconstruction | completed | N/A | 90 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Jan 25, 2024 | clinicaltrials |
| NCT03511391 | CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors(CHEERS) | completed | Phase 2 | 99 | University Hospital, GhentOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT03543813 | PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL | completed | Phase 1 / Phase 2 | 133 | CytomX TherapeuticsINDUSTRY | 4 | Jan 23, 2024 | clinicaltrials |
| NCT02244463 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | completed | Phase 1 / Phase 2 | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT00342446 | A Follow-up Study of Women Evaluated and Treated for Infertility | completed | — | 12,193 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02865135 | Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer | completed | Phase 1 / Phase 2 | 11 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02718820 | Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer | completed | Phase 1 / Phase 2 | 22 | Medical University of ViennaOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT04145180 | Effectiveness of a Physical Recovery Program for Head and Neck Cancer Patients (3C-CUIDATE)(3C-CUIDATE) | completed | N/A | 55 | Universidad de GranadaOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT04437030 | Multiparametric Photoacoustic Imaging in the Course of Radiation Therapy of Malignant Head and Neck Tumors | completed | N/A | 30 | University Hospital HeidelbergOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT03749460 | Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers | completed | Phase 1 / Phase 2 | 20 | University of WashingtonOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT02757222 | Dose Escalation Versus Standard in Laryngopharyngeal Cancers(INTELHOPE) | completed | N/A | 100 | Tata Medical CenterOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT01709435 | Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 2 | Dec 22, 2023 | clinicaltrials |
| NCT02379039 | Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer(MORRIS) | completed | — | 118 | Umeå UniversityOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | completed | Phase 1 | 277 | MacroGenicsINDUSTRY | 8 | Dec 21, 2023 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT02482168 | Study of the CD40 Agonistic Monoclonal Antibody APX005M | completed | Phase 1 | 43 | Apexigen America, Inc.INDUSTRY | 1 | Dec 20, 2023 | clinicaltrials |
| NCT03894891 | Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer | completed | Phase 2 | 6 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT05793957 | Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms | completed | N/A | 50 | OHSU Knight Cancer InstituteOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT06171464 | Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer | completed | — | 19 | IRCCS San RaffaeleOTHER | 0 | Dec 14, 2023 | clinicaltrials |
| NCT04379505 | Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT)(PEAQ-RT) | completed | N/A | 10 | Washington University School of MedicineOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT05137639 | Free Skin Grafting to Reconstruct Donor Sites After Radial Forearm Flap Harvesting | completed | N/A | 32 | Wuerzburg University HospitalOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT03229278 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | completed | Phase 1 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT05226065 | The Relationship Between Intake of Macro and Micronutrients With Clinical Outcomes of Head and Neck Cancer Patients | completed | — | 112 | Indonesia UniversityOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT06152055 | Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal | completed | — | 76 | Tribhuvan University, NepalOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT01172470 | Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients | completed | Phase 2 | 34 | University of ChicagoOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT01185158 | A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma | completed | Phase 2 | 46 | University of ChicagoOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT01187472 | Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer | completed | — | 35 | University of ChicagoOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT04717765 | Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention | completed | N/A | 60 | University of Santiago de CompostelaOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT04454697 | Tissue Retractors for Radiation Therapy of Head and Neck Tumors(GUARD) | completed | N/A | 34 | University Hospital HeidelbergOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT04393506 | Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma | completed | Phase 1 | 21 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT04473716 | Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients | completed | Phase 1 | 20 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT05455632 | Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery | completed | — | 192 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06143761 | Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer(HNC-SYSU-005) | completed | — | 206 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT04925700 | The Oral Microbiome in OSCC | completed | N/A | 20 | University of IowaOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05594069 | Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients | completed | N/A | 87 | Peking UniversityOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05792228 | A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting | completed | N/A | 92 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT06124469 | UNN-RADS Scale for Diagnosing Lymph Node Metastasis in Patients With History of Thyroid Cancer | completed | — | 99 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Nov 9, 2023 | clinicaltrials |
| NCT03993561 | Treatment Summary and Survivorship Care Plans (TSSP)(SHARE) | completed | N/A | 18 | Western University, CanadaOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT02178436 | Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Mohammed Najeeb Al HallakOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT04337853 | Radiotherapy of Tongue Cancer Using an Intraoral Stent | completed | Phase 1 | 13 | Oslo University HospitalOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT03265873 | Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers(CONTOUR) | completed | — | 100 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Oct 26, 2023 | clinicaltrials |
| NCT03906058 | Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy | completed | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | Oct 25, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Feb 5, 2024source: clinicaltrials